Joan Font-Burgada

4.1k citations

20 papers · 2.6k indexed · 3 hit papers · h-index 15

Co-authors: Michael Karin Beicheng Sun Hayato Nakagawa Debanjan Dhar Hannah Carter Shabnam Shalapour Koji Taniguchi Atsushi Umemura
Topics: Immunotherapy and Immune Responses (5 papers)Liver Disease Diagnosis and Treatment (4 papers)vaccines and immunoinformatics approaches (4 papers)
Cited by: Hepatology Immunology Cancer Research
Journals: Nature Cell Proceedings of the National Academy of Sciences
Partner nations: United States Spain Japan

In The Last Decade

Joan Font-Burgada

20 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy

2015 429 citations Shabnam Shalapour, Joan Font-Burgada et al. Nature profile →
ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development

2014 396 citations Hayato Nakagawa, Atsushi Umemura et al. Cancer Cell profile →
Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer

2015 361 citations Joan Font-Burgada, Shabnam Shalapour et al. Cell profile →

Peers

Countries citing papers authored by Joan Font-Burgada

Since Specialization

Citations

This map shows the geographic impact of Joan Font-Burgada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Font-Burgada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Font-Burgada more than expected).

Fields of papers citing papers by Joan Font-Burgada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Font-Burgada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Font-Burgada. The network helps show where Joan Font-Burgada may publish in the future.

Co-authorship network of co-authors of Joan Font-Burgada

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Font-Burgada. A scholar is included among the top collaborators of Joan Font-Burgada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Font-Burgada. Joan Font-Burgada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Paraoxonase-like APMAP maintains endoplasmic-reticulum-associated lipid and lipoprotein homeostasis 2025 ·Developmental Cell ·Blessy Paul,(unknown),Rupali Ugrankar,(unknown),Son N. Tran,Gonçalo Vale,(unknown),C. L. Hewett,Jeffrey G. McDonald,Joan Font-Burgada,Thomas P. Mathews,Steven Farber,W. Mike Henne	1
2	Universal open MHC-I molecules for rapid peptide loading and enhanced complex stability across HLA allotypes 2023 ·Proceedings of the National Academy of Sciences ·Yi Sun,(unknown),(unknown),(unknown),(unknown),S. K. Gupta,(unknown),Joan Font-Burgada,George M. Burslem,Nikolaos G. Sgourakis	13
3	Characterizing MHC-I Genotype Predictive Power for Oncogenic Mutation Probability in Cancer Patients 2020 ·Methods in molecular biology ·(unknown),Michael Slifker,David Rossell,Joan Font-Burgada	2
4	Inflammation in Primary and Metastatic Liver Tumorigenesis–Under the Influence of Alcohol and High-Fat Diets 2020 ·Nutrients ·(unknown),(unknown),Joan Font-Burgada	19
5	RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation 2019 ·Cellular and Molecular Gastroenterology and Hepatology ·Jerry Wong,Ricard Garcia‐Carbonell,Matija Zelic,Samuel B. Ho,Brigid S. Boland,(unknown),(unknown),Soumita Das,Núria Planell,Philip A. Harris,Joan Font-Burgada,Koji Taniguchi,John Bertin,Azucena Salas,Manolis Pasparakis,(unknown),Michelle A. Kelliher,Michael Karin,Mónica Gumá	33
6	Evolutionary Pressure against MHC Class II Binding Cancer Mutations 2018 ·Cell ·Rachel Marty Pyke,(unknown),Rany M. Salem,Joan Font-Burgada,Maurizio Zanetti,Hannah Carter	157
7	Integrative genomic analysis of mouse and human hepatocellular carcinoma 2018 ·Proceedings of the National Academy of Sciences ·Michelle T. Dow,Rachel Marty Pyke,Brian Tsui,Ludmil B. Alexandrov,Hayato Nakagawa,Koji Taniguchi,Ekihiro Seki,Olivier Harismendy,Shabnam Shalapour,Michael Karin,Hannah Carter,Joan Font-Burgada	61
8	MHC-I Genotype Restricts the Oncogenic Mutational Landscape 2017 ·Cell ·Rachel Marty,Saghar Kaabinejadian,David Rossell,Michael Slifker,Joris van de Haar,H. Billur Engin,Nicola de Prisco,Trey Ideker,William H. Hildebrand,Joan Font-Burgada,Hannah Carter	225
9	MHC-I genotype drives early immune selection of oncogenic mutations 2017 ·Molecular & Cellular Oncology ·Rachel Marty,Nicola de Prisco,Hannah Carter,Joan Font-Burgada	4
10	Obesity and Cancer: The Oil that Feeds the Flame 2016 ·Cell Metabolism ·Joan Font-Burgada,Beicheng Sun,Michael Karin	275
11	Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapybreakdown → 2015 ·Nature ·Shabnam Shalapour,Joan Font-Burgada,Giuseppe Di,Zhenyu Zhong,Elsa Sánchez‐López,Debanjan Dhar,Gerald Willimsky,Massimo Ammirante,Amy Strasner,Donna E. Hansel,Christina Jamieson,Christopher J. Kane,Tobias Klatte,Peter Birner,Lukas Kenner,Michael Karin	429
12	Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation 2015 ·Cell Death and Differentiation ·Alexander Wree,Casey D. Johnson,Joan Font-Burgada,Akiko Eguchi,Davide Povero,Michael Karin,Ariel E. Feldstein	22
13	Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancerbreakdown → 2015 ·Cell ·Joan Font-Burgada,Shabnam Shalapour,Suvasini Ramaswamy,Brian Hsueh,David Rossell,Atsushi Umemura,Koji Taniguchi,Hayato Nakagawa,Mark A. Valasek,Ye Li,Janel L. Kopp,Maike Sander,Hannah Carter,Karl Deisseroth,Inder M. Verma,Michael Karin	361
14	dDsk2 regulates H2Bub1 and RNA polymerase II pausing at dHP1c complex target genes 2015 ·Nature Communications ·(unknown),(unknown),Joan Font-Burgada,Óscar Reina,(unknown),Camille Stephan‐Otto Attolini,Ivan García-Bassets,Fernando Azorı́n	16
15	Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis 2014 ·Proceedings of the National Academy of Sciences ·Hayato Nakagawa,Yohko Hikiba,Yoshihiro Hirata,Joan Font-Burgada,Kei Sakamoto,Yoku Hayakawa,Koji Taniguchi,Atsushi Umemura,Hiroto Kinoshita,Kosuke Sakitani,Yuji Nishikawa,Kenji Hirano,Tsuneo Ikenoue,Hideaki Ijichi,Debanjan Dhar,Wataru Shibata,Masao Akanuma,Kazuhiko Koike,Michael Karin,Shin Maeda	95
16	ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Developmentbreakdown → 2014 ·Cancer Cell ·Hayato Nakagawa,Atsushi Umemura,Koji Taniguchi,Joan Font-Burgada,Debanjan Dhar,Hisanobu Ogata,Zhenyu Zhong,Mark A. Valasek,Ekihiro Seki,Juan Hidalgo,Kazuhiko Koike,Randal J. Kaufman,Michael Karin	396
17	Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade 2014 ·Proceedings of the National Academy of Sciences ·Xuefeng Wu,Weizhou Zhang,Joan Font-Burgada,Trenis D. Palmer,Alexander Hamil,Subhra K. Biswas,Michael Poidinger,Nicholas Borcherding,Qing Xie,Lesley G. Ellies,Nikki K. Lytle,Li‐Wha Wu,Raymond G. Fox,Jing Yang,Steven F. Dowdy,Tannishtha Reya,Michael Karin	91
18	Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling 2013 ·Cell ·Guobin He,Debanjan Dhar,Hayato Nakagawa,Joan Font-Burgada,Hisanobu Ogata,Yuhong Jiang,Shabnam Shalapour,Ekihiro Seki,Shawn Yost,Kristen Jepsen,Kelly A. Frazer,Olivier Harismendy,Maria Hatziapostolou,Dimitrios Iliopoulos,Atsushi Suetsugu,Robert M. Hoffman,Ryosuke Tateishi,Kazuhiko Koike,Michael Karin	358
19	chroGPS, a global chromatin positioning system for the functional analysis and visualization of the epigenome 2013 ·Nucleic Acids Research ·Joan Font-Burgada,Óscar Reina,David Rossell,Fernando Azorı́n	2
20	Drosophila HP1c isoform interacts with the zinc-finger proteins WOC and Relative-of-WOC to regulate gene expression 2008 ·Genes & Development ·Joan Font-Burgada,David Rossell,Herbert Auer,Fernando Azorı́n	55

About Joan Font-Burgada

Joan Font-Burgada is a scholar working on Hepatology, Immunology and Cancer Research, having authored 20 papers that have together received 2.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and vaccines and immunoinformatics approaches (4 papers). The work is most often cited by research in Hepatology (493 citations), Immunology (799 citations) and Cancer Research (506 citations). Joan Font-Burgada has collaborated with scholars based in United States, Spain and Japan. Frequent co-authors include Michael Karin, Beicheng Sun, Hayato Nakagawa, Debanjan Dhar, Hannah Carter, Shabnam Shalapour, Koji Taniguchi, Atsushi Umemura, David Rossell and Zhenyu Zhong. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact